Evidence map›Paper›PMID 29221436›Full record

ArticleBMC nephrology2017

Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study.

Ala'a Alkerwi, Nicolas Sauvageot, Illiasse El Bahi, Charles Delagardelle, Jean Beissel, Stephanie Noppe, Paul J Roderick, Jennifer S Mindell, Saverio Stranges

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Global health inequalities of chronic kidney disease: a meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Ala'a AlkerwiDepartment of Population Health, Epidemiology and Public Health Research Unit, Luxembourg Institute of Health (LIH) (formerly CRP-Santé), Grand-Duchy of Luxembourg, 1A-B, rue Thomas Edison, L-1445, Strassen, Luxembourg. alaa.alkerwi@lih.lu.ORCID http://orcid.org/0000-0002-7448-3936
Nicolas SauvageotDepartment of Population Health, Epidemiology and Public Health Research Unit, Luxembourg Institute of Health (LIH) (formerly CRP-Santé), Grand-Duchy of Luxembourg, 1A-B, rue Thomas Edison, L-1445, Strassen, Luxembourg.
Illiasse El BahiDepartment of Population Health, Epidemiology and Public Health Research Unit, Luxembourg Institute of Health (LIH) (formerly CRP-Santé), Grand-Duchy of Luxembourg, 1A-B, rue Thomas Edison, L-1445, Strassen, Luxembourg.
Charles DelagardelleService of Cardiology, Centre Hospitalier du Luxembourg, Grand-Duchy of Luxembourg, Luxembourg, Luxembourg.
Jean BeisselService of Cardiology, Centre Hospitalier du Luxembourg, Grand-Duchy of Luxembourg, Luxembourg, Luxembourg.
Stephanie NoppeService of Cardiology, Centre Hospitalier du Luxembourg, Grand-Duchy of Luxembourg, Luxembourg, Luxembourg.
Paul J RoderickAcademic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, South Academic Block, Tremona Road, Hampshire, Southampton, SO16 6YD, UK.
Jennifer S MindellResearch Department of Epidemiology & Public Health, UCL (University College London), London, WC1E 6BT, UK.
Saverio StrangesDepartment of Population Health, Epidemiology and Public Health Research Unit, Luxembourg Institute of Health (LIH) (formerly CRP-Santé), Grand-Duchy of Luxembourg, 1A-B, rue Thomas Edison, L-1445, Strassen, Luxembourg.
Centre Hospitalier de Luxembourg · LULuxembourg Institute of Health · LUSouthampton General Hospital · GBUniversity College London · GBWestern University · CA

Funding

Fonds National de la Recherche Luxembourg DIQUA-LUX, 5870404
6 · The paper itself

Abstract

backgroundEvidence on stages of renal impairment and related risk factors in Luxembourg is lacking. This study aimed to assess the prevalence of chronic kidney disease (CKD) and identify potential correlates among the general population, using the recent definition suggested by the Kidney Disease Improving Global Outcomes guidelines.

methodsData analysed from 1361 participants aged 18-69 years, enrolled in the Observation of Cardiovascular Risk Factors in Luxembourg (ORISCAV-LUX) study, 2007-08. Descriptive and multivariable logistic regression analyses were performed to identify demographic, socio-economic, behavioural, and clinical factors associated with CKD, defined as a single estimated glomerular filtration rate (eGFR) measure <60 ml/min/1.73m

resultsOverall, 6.3% had CKD, including 4.4% and 0.7% with moderate and severe macroalbuminuria respectively. 0.1% had kidney failure (eGFR < 15 ml/min/1.73 m

conclusionThe national baseline prevalence estimate of CKD, a neglected public health problem, stresses the benefit of early detection particularly in high-risk subjects with associated cardiovascular pathologies (e.g. hypertension, diabetes), to prevent and defray costs related to eventual complications.

Indexed as

AlbuminuriaRenal Insufficiency, ChronicAdultCardiovascular DiseasesComorbidityCreatinineDemographyEarly DiagnosisExerciseFemaleGlomerular Filtration RateHumansLuxembourgMaleMiddle AgedPrevalenceCreatinineAlbuminuriaChronic kidney disease (CKD)EpidemiologyGlomerular filtration ratePopulation-based study

Identifiers

PMID29221436
PMCPMC5723040
OpenAlexW2774598175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.